Aigen Investment Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-33
Closed -$1K 1043
2020
Q1
$1K Buy
+33
New +$786 ﹤0.01% 1225

Other funds holding IRMD

Aigen Investment Management's IRMD Position: Q2 2020 in Review

Aigen Investment Management sold out of iRadimed (IRMD) in Q2 2020, closing a stake of 33 shares — an estimated $1K sold.

Aigen Investment Management first reported a position in IRMD in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 65 funds tracked by Wall St. Rank hold IRMD as of Q2 2020.

  • Aigen Investment Management reported no remaining iRadimed position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 33 iRadimed shares in Q2 2020, an estimated $1K.
  • Aigen Investment Management first reported a position in iRadimed in Q1 2020 and held it in 1 quarter.
  • Aigen Investment Management's iRadimed position peaked at $1K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held iRadimed as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.